Related Experiment Videos
New therapeutic approaches in atopic dermatitis
1Department of Dermatology, University of Michigan Medical School, Ann Arbor.
Clinical Reviews in Allergy
|January 1, 1993
Summary
New atopic dermatitis (AD) therapies target immune cells and pathways. While novel treatments show promise, fundamental management of AD remains crucial for symptom control.
Area of Science:
- Immunology
- Dermatology
- Pharmacology
Background:
- Atopic dermatitis (AD) pathogenesis involves immune cells, with cyclosporin A efficacy and bone marrow transplant outcomes highlighting immune cell criticality.
- Recent advances in understanding AD pathogenesis enable novel therapeutic strategies currently under clinical investigation.
Purpose of the Study:
- To review novel and emerging therapeutic approaches for atopic dermatitis (AD).
- To discuss the role of immune cells and specific pathways in AD pathogenesis and therapeutic targeting.
Main Methods:
- Review of current clinical trials and research on AD therapies.
- Analysis of immunomodulatory agents, T-cell inhibitors, phototherapy, and traditional medicine.
Main Results:
- Immunosuppressants (azathioprine, methotrexate), T-cell activation inhibitors, and interferon-gamma show potential.
- Longer-wavelength phototherapy may offer advantages over UVB therapy.
- Herbal mixtures and dietary modifications are under evaluation with limitations.
Conclusions:
- Targeted immunomodulation offers a more specific approach than broad immunosuppression for AD.
- Further research is needed to establish the safety and efficacy of novel AD treatments.
- Fundamental AD management, including trigger avoidance and barrier repair, remains essential.